To confirm a diagnosis and determine the stage of the disease, your doctor will use a series of tests: Biopsy: This is the ...

A doctor and survivor share what you need to know. Named after the 19th-century scientist who first described abnormal masses ...

Lymphoma is a type of cancer that affects the lymphatic system, a vital part of the immune system. For individuals facing this diagnosis, understanding the range of treatment options available can be ...

What Is Marginal Zone Lymphoma? Marginal zone lymphoma (MZL) isn’t one disease. It’s a group of rare, slow-growing blood cancers. They’re known as non-Hodgkin lymphomas because they start in your ...

Stage 3 lymphoma is a type of cancer that starts in a type of white blood cell called lymphocytes and has spread to lymph nodes on both sides of the diaphragm. It may also be in other organs near ...

Lymphoma is a type of blood cancer that targets the lymphatic system. This type of cancer impacts the cells that are a part of one's immune system, according to the American Cancer Society. There are ...

MCHL is a common type of classic Hodgkin’s lymphoma, most common in people with HIV infection or children with a history of Epstein-Barr virus infection. It has a generally favorable outlook. Mixed ...

It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...

About 30 percent of all non-Hodgkin lymphoma diagnoses in the United States are DLBCL. Although it is an aggressive cancer that can spread quickly, it is treatable. These can be symptoms of many ...

Beloved Australian actor, Magda Szubanski, has revealed she's been diagnosed with a "very rare, very aggressive, very serious" blood cancer called mantle cell lymphoma. In a post on social media on ...

An innovative approach could transform the treatment landscape for DLBCL patients, offering hope to those who might otherwise ...

In a matched analysis involving 110 patients with transformed indolent non-Hodgkin lymphoma (TriNHL) and 391 patients with de ...